Evolent Health, Inc. (EVH) research
Evolent Health, Inc.- Sector
- Health Care
- Last price
- $3.80
- As of
Evolent Health, Inc. (EVH): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-06.
As of . Source: SEC EDGAR filings for EVH. Method and limitations.
Share the EVH intelligence card
See EVH live in the terminal
Track EVH's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live EVH terminal, freeActive signals for EVH
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +794% to EVH (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +794% to EVH (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +794% to EVH (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 75% of EVH (2026Q1)
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 61.4% - EPS $-0.02 vs $-0.0518 estimate
FREE, NO ACCOUNT
Every signal on EVH, as it fires
You are seeing 5 of 8 signals recorded on EVH since 2026-05-26.
The five above landed across 4 days. The other 3 were recorded on those same days. 4 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in EVH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 30050B101 · 2026Q2 | $27.7M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 30050BAH4 · 2026Q2 | $14.9M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 30050B101 · 2026Q2 | $6.8M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 30050B101 · 2026Q2 | $2.6M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 30050B101 · 2026Q2 | $1.6M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 30050BAJ0 · 2026Q2 | $229K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, EVH
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
EVH against its peers
EVH's operating margin of -21.9% ranks in the 25th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | EVH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.9B USD | 323M USD | 90 | 25 |
| Gross margin | n/a | 61.0% | n/a | 14 |
| Operating margin | -21.9% | -4.6% | 25 | 25 |
| Net margin | -28.5% | -7.7% | 25 | 25 |
| Return on equity | -128.7% | -8.7% | 6 | 24 |
| P / E | n/a | 47.6x | n/a | 5 |
Peers (25): CCRN, SGHT, SLP, CTEV, CERS, FLGT, ANGO, EHAB, AHCO, VREX, RXST, HSTM, TALK, BVS, STAA, CSTL, PRCT, IRMD, TDOC, GDRX, TNDM, USPH, CERT, INGN, OMDA. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (EVH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more EVH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to EVHand get the insider, 13F, options, and confluence read in one view.